Highlights
NYSE: ACT       Advisorshares Vice ETF
Last Price Today's Change   Day's Range   Trading Volume
25.812   -0.658 (2.49%)  25.42 - 26.01  8,337

Overview

 
Avg Volume (4 weeks):2,768
4 Weeks Range:25.42 - 26.98
4 Weeks Price Volatility (%):
25.13%
52 Weeks Range:16.16 - 26.98
52 Weeks Price Volatility (%):
89.21%
Average Price Target: 340.00
Price Target Upside/Downside: +314.188

Headlines



No recent Headlines for this stock.


Business Background

Actavis plc is a global, integrated specialty pharmaceutical company. The Company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company produces and markets generic, branded generic, branded and over-the-counter (OTC) pharmaceutical products covering all therapeutic classes. The Company's product formulations include modified release, solid oral dosage, semi-solids, suspensions, transdermals, suppositories, creams, ointments, liquids and injectables. In October 2013, Actavis Inc acquired Warner Chilcott PLC and in connection with the acquisition, Actavis Inc and Warner Chilcott PLC have been combined under a new company, Actavis plc.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1834  3675  194  3598 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 1.38+1.38 
 ONTX 0.364+0.042 
 AVP 5.60-0.05 
 AABA 19.630.00 
 TGE 22.39+0.81 
 APY 10.34+0.25 
 AKRX 0.09-0.094 
 PGNX 4.10-0.425 
 XOG 0.271-0.062 
 TUES 0.2820.00 
PARTNERS & BROKERS